Navigation Links
Novel aspects of histamine research discussed in Versita open access book

Histamine H4 Receptors: A novel Drug Target for Immunomodulation and Inflammation, edited by Professor Holger Stark, is a new Open Access Book comprising key results from the highly acclaimed Action BM0806, held by COST (European Cooperation in Science and Technology), which was instituted to champion and promote a multidisciplinary approach to H4R research, and focused on the current state of play pertaining to the basic understanding and the huge therapeutic potential of this new drug target. The objective of this project was to advance awareness of the newly identified histamine receptor.

The book describes molecular signaling mechanism, the function as well as the localization of this receptor subtype, along with its influence on physiological and pathophysiological properties. It offers an insight into a range of perspectives on H4R research, and a thorough analysis of the possibilities for novel therapeutic inventions and exploitation, allowing for newly designed compounds as well as numerous biochemical in vitro and in vivo models on different species.

Chapter by chapter, different aspects of histamine research are presented and discussed. The contributing authors were all active members of Action BM0806 and as a result, the book covers the most original and topical aspects of histamine research. One of them is the role of histamine in allergic reactions, which was assumed to have been clarified for many decades. Presently, the increased understanding of histamine and its functions places it at the centre stage in the orchestration of the innate immune response and lead-up to the adaptive response. Professor Madeleine Ennis (Secretary, COST Action BM0806) and colleagues discuss in detail the evidence for the roles of various histamine receptors (particularly the H4R) in immune cell function, spanning eosinophils, monocytes, basophils, mast cells and neutrophils. Another newsworthy section, dedicated to histamine and cancer, is written by one of the leading specialists in the field Professor Elena S. Rivera, a global expert on histamine and cell proliferation, who provides exciting new data that supports the H4R as a novel target for a range of refractory cancers. Finally, the closing chapter discusses the non-receptor role of histamine a fascinating topic, albeit so far largely under-studied by the histamine community.

Considering its cross-sectional approach, the book will benefit not only societies and professional organizations, but all scientists involved in biogenic amine research and those with special emphasis on histamine research should find it an invaluable read. As Dr. Paul L Chazot, President of European Histamine Research Society points out: "This new Book offers something for everyone across disciplines, and individuals with either a deep or passing interest in histamine will be kept entertained and informed."


Contact: Maria Hrynkiewicz

Related biology news :

1. Novel LEDs pave the way to cheaper displays
2. Novel technique for suturing tissue-engineered collagen graft improves tendon repair
3. Novel mutations define 2 types of bone tumor
4. NIH funds development of novel robots to assist people with disabilities, aid doctors
5. Mutations in novel tumor suppressor gene associated with early onset breast cancer
6. IRICoR and Université de Montréal license a novel program for early-onset morbid obesity to Pfizer
7. Novelty of eco-friendly bamboo garments lures consumers -- if the price is right, Baylor study shows
8. Novel mechanism discovered in first line of immune defense
9. Novel avian influenza A virus has potential for both virulence and transmissibility in humans
10. Researchers develop novel polymer to help oral medications reach the bloodstream
11. Novel approach to gene regulation can activate multiple genes simultaneously
Post Your Comments:
Related Image:
Novel aspects of histamine research discussed in Versita open access book
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... ... 10, 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, ... The bold new look is part of a transformation to increase awareness, appeal ... growth period. , It will also expand its service offering from its signature gourmet ...
(Date:10/10/2017)... DALLAS , Oct. 10, 2017 International research firm ... IoT Strategy, will speak at the TMA 2017 Annual Meeting , ... key trends in the residential home security market and how smart safety ... ... "The ...
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
Breaking Biology Technology: